We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DMAC market cap is 269.39M. The company's latest EPS is USD -0.4532 and P/E is -13.95.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.16M | -5.85M | -5.74M | -5.64M | -6.88M |
| Net Income | -4.47M | -5.16M | -5.15M | -5.12M | -6.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.59M | -12.7M | -13.65M | -14M | -21.27M |
| Net Income | -10.65M | -12.29M | -13.59M | -13.68M | -19.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 58.14M | 54.16M | 49.26M | 56.79M | 52.52M |
| Total Liabilities | 2.51M | 3.1M | 2.91M | 3.38M | 4.56M |
| Total Equity | 55.63M | 51.06M | 46.35M | 53.42M | 47.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.05M | 28.1M | 45.55M | 34.4M | 54.16M |
| Total Liabilities | 1.44M | 2.08M | 1.53M | 2.57M | 3.1M |
| Total Equity | 7.62M | 26.01M | 44.02M | 31.83M | 51.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.92M | -18.73M | -6.65M | -11.17M | -15.64M |
| Investing | -24.42M | -18.3M | 4.21M | 8.94M | 3.36M |
| Financing | 36.84M | 36.84M | -1,000 | 11.75M | 11.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.1M | -9.19M | -12.25M | -11.51M | -18.73M |
| Investing | -3.91M | -16.13M | -20.54M | 11.54M | -18.3M |
| Financing | 70k | 28.85M | 30.09M | -6k | 36.84M |
| Market Cap | 269.39M |
| Price to Earnings Ratio | -13.95 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 59.51 |
| Price to Book Ratio | 5.29 |
| Dividend Yield | - |
| Shares Outstanding | 42.76M |
| Average Volume (1 week) | 158.75k |
| Average Volume (1 Month) | 93.63k |
| 52 Week Change | 132.47% |
| 52 Week High | 6.41 |
| 52 Week Low | 2.14 |
| Spread (Intraday) | 0.4 (6.23%) |
| Company Name | DiaMedica Therapeutics Inc |
| Address |
301 carlson parkway, suite 210 minneapolis, minnesota 55305 |
| Website | https://www.diamedica.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
